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Abstract-The authors present the computed tomographic findings in a patient with malignant gestational 
trophoblastic neoplasia. No similar case has been described on computed tomography. The interesting 
aspects of the case and a brief review of this clinical entity is discussed. 
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INTRODUCTION 
Gestational trophoblastic neoplasia (GTN) includes the entities of choriocarcinoma, invasive molar 
disease and metastatic molar disease [l]. All are sequelae to human pregnancy. Approximately half 
of all patients who develop malignant GTN have had an antecedent molar gestation, while the 
remaining half have had other types of antecedent pregnancy, including term delivery, abortion, 
therapeutic or spontaneous, stillbirth, or even ectopic gestation. 
Molar pregnancy is generally suspected in the setting of abnormal bleeding, abnormal uterine 
growth and absent fetal heart tones. The condition is usually diagnosed by ultrasound and treated 
by suction curettage. Twenty percent of patients with hydatidiform moles can be expected to 
develop subsequent malignant sequelae [2]. For this reason it is mandatory to follow these patients 
with serial levels of beta human chorionic gonadotropin (Beta-HCG). If these levels persist or 
increase then the patients must be assessed for possible metastatic disease. It has been recently 
indicated that the risk of GTN in molar pregnancies is significantly increased in pregnancies large 
for dates with a uterus or more than 20 weeks’ gestational size and with theta-lutein cysts greater 
than 5 cm in diameter [Z, 31. The uterine abnormality and the bilateral theta-lutein cysts are well 
demonstrated in this report of the CT findings in a patient with metastatic molar disease. 
CASE REPORT 
A 26-yr old white female, gravida 1 para 1, sought medical advice in September 1980, for abnor- 
mal vaginal bleeding. Her last menstrual period had been two months earlier, and she thought she 
was pregnant. D & C was performed, and pathologic examination of the curetted specimen revealed 
grade III of III molar tissue. Serial serum beta-HCG increased markedly in subsequent weeks and a 
repeat D & C in November yielded grade III molar tissue. The patient was referred to the Univer- 
sity Hospital for staging and initiation of chemotherapy for trophoblastic disease. Physical and 
pelvic examination disclosed bilateral large ovarian cysts, each about 10-12 cm in size, suggestive of 
theta-lutein cysts. The uterus was slightly enlarged to about the size of a 7 week pregnancy, 
anteverted and smooth with no vaginal disease palpated. 
Chest X-rays and polydirectional lung tomograms revealed 2 metastatic nodules. A CT scan of 
the brain was normal. CT scan of the abdomen did not demonstrate liver metastases. There was no 
evidence of adenopathy or other intra-abdominal metastases however, bilateral large, septated fluid- 
filled masses were noted, each just anterior to the iliopsoas and ureter extending to the anterior 
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Fig. I. (A-C) Bilateral theta-lutein cysts: large multiseptated masses of fluid density (cursor marker indi- 
cates 13 Hounsfield units) extending upwards from the pelvis (A) into midabdomen (B,C). The margins of 
the masses are well demarcated with displacement of contrast filled loops of bowel posteriorly and laterally. 
abdominal wall and displacing bowel to either side (Fig. 1). The appearance was felt to be consistent 
with large bilateral theta-lutein cysts of the ovaries. The uterus was enlarged with low attenuation 
areas (Fig. 2). It measured 1Ocm in both AP and transverse dimensions. Sonography was not 
performed. 
Significant laboratory tests included HCG on 24 h urine with HCG daily output of between 33,500 
and 50,215 units. On the basis of all the above data, the patient was enrolled in a low risk metastatic 
trophoblastic neoplasia treatment group, (Class IV in the New England Trophoblastic Disease 
Fig. 2. Enlarged uterus (10 x 1Ocm) containing 
areas of low attenuation. Curettage 3 weeks prior 
had demonstrated grade III molar tissue. 
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Center classification), and was started on methotrexate therapy. Four months later and after 9 
courses of methotrexate, physical and pelvic examination had returned to normal. Pulmonary 
nodules had resolved on chest radiographs and beta-HCG levels were not detectable. 
DISCUSSION 
The usefulness of ultrasonography for the diagnosis of trophoblastic disease has been well estab- 
lished [4-63. In our patient CT demonstrated bilateral large multiseptated masses of fluid density 
closely resembling the classic sonographic appearance of theta-lutein cysts well described by 
Kobayashi and others [7, S]. The cystic masses were well circumscribed and separate from other 
structures except for displacement of adjacent bowel. A histologic diagnosis cannot be offered by CT 
and other multiseptated cystic masses might have been included in the differential diagnosis, but the 
clinical course was most consistent with the CT impression of theta-lutein cysts. CT has recently 
been reported to be useful in the imaging of tumors of ovarian origin as small as 3 cm in maximal 
diameter [9]. 
Theta-lutein cysts in GTN are due to excessive HCG produced by the molar pregnancy. Patients 
who have these cysts will have a significantly greater risk of persistent trophoblastic disease [3]. 
Palpable theta-lutein cysts are present in about 30% of molar pregnancies; however, the reported 
incidence of these masses on ultrasound examination has been as high as 50% [4]. In a recently 
reported series 5 of 16 patients studied with ultrasonography had cysts of less than 300 cm3 in 
volume, which were not palpable on physical examination [lo]. 
Recognition of invasive trophoblastic disease on ultrasound depends on the presence of hemorrha- 
gic necrosis within the myometrium, manifested as areas of irregular hypoechoicity and high ampli- 
tude echoes in clusters [S]. However, occasionally, invasive trophoblastic disease can be present 
without recognizable textural abnormalities of the uterus on ultrasound [IS]. Even curettage may not 
identify residual disease present deep in the myometrium [ 11. Although definitive pathological proof 
was not obtained, the CT appearance of uterine enlargement with irregular areas of low attenuation 
in our patient, was highly suggestive of invasive trophoblastic disease. 
In patients with GTN, metastatic deposits can be found in the gastrointestinal and genitourinary 
tracts as well as in the liver, lung and brain. Even in this highly responsive disease, cerebral, hepatic 
and bowel metastases are difficult to control. Detection of trophoblastic disease in these sites places 
the patient in a high risk category with poor prognosis and demands a much more aggressive 
therapeutic approach. Cranial CT is the preferred diagnostic modality in the search for metastatic 
disease to the brain [l, 111. Although evaluation of liver involvement by scintigraphy is generally 
advocated, the high degree of accuracy of CT in detecting hepatic neoplasm [l 11, as well as other 
areas of abdominal involvement, may be of benefit in selected patients. Familiarity with the CT 
appearance we describe may be also helpful in those patients in whom invasive trophoblastic disease 
is not suspected, i.e. those without antecedent mole and whose preceding pregnancy occurred years 
previously (or who actually had a recent pregnancy with early unrecognized abortion). In those 
instances determination of serum beta-HCG level, a highly sensitive and accurate tumor marker, 
may be obtained to confirm the CT diagnosis. 
SUMMARY 
The computed tomographic findings in a patient with gestational trophoblastic neoplasia are 
presented for the first time. Although computed tomography is not advocated as the modality of 
choice for imaging of the primary disease, awareness of the CT appearance described may be helpful 
in cases without clear-cut history pointing towards gestational trophoblastic malignancy. The poss- 
ible role of computed tomography in the search for distant metastases is discussed. 
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